+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Payers Try New Approaches To Manage Molecular Diagnostics: Some payers require prior authorization for molecular diagnostic testing and some don't. And some payers are looking at other options



Payers Try New Approaches To Manage Molecular Diagnostics: Some payers require prior authorization for molecular diagnostic testing and some don't. And some payers are looking at other options



Biotechnology Healthcare 7(3): 26-30




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054900407

Download citation: RISBibTeXText

PMID: 22478827


Related references

Multiple payers, commonality and free-riding in health care: Medicare and private payers. Journal of Health Economics 21(6): 1049-1069, 2002

I.T. part of payers' new game plans. Payers are using software to improve customer service and health. Health Data Management 11(6): 66-8 70, 2003

Oncology management programs for payers and physicians: evaluating current models and diagnosing successful strategies for payers and physicians. Journal of Oncology Practice 7(3 Suppl): E46s-E49s, 2011

Hagglers, slow payers, and no payers. Journal of the American Veterinary Medical Association 194(10): 1412-1413, 1989

One payer, two payers, three payers, more? Coverage for all--a single party-payer system is the answer. Michigan Medicine 105(5): 16-16, 2006

One payer, two payers, three payers, more? Universal coverage without a single party-payer. Michigan Medicine 105(5): 17, 2006

How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?. Value in Health 21: S43-S44, 2018

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer. Journal of Comparative Effectiveness Research 2(4): 461-477, 2013

Variety of approaches taken by payers. Hospitals 58(24): 56 58, 1984

Salivary diagnostics--a new industry: perspectives from business development, government, regulatory, and payers. Advances in Dental Research 23(4): 369-374, 2011

Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level. Therapie 65(4): 329-334, 2010

Increasing Supply of and Demand for Evidence-Based Psychotherapy: Near-Term Options for Payers and Policymakers. Depression and Anxiety 32(11): 809-810, 2015

Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers. Personalized Medicine 10(3): 235-243, 2013

Vestibular evoked myogenic potential testing: Payment policy review for clinicians and payers. Neurology. Clinical Practice 8(2): 129-134, 2018

Aggregating Claims Data Across Payers: Approaches, Challenges, and Lessons Learned From the Comprehensive Primary Care Initiative. American Journal of Medical Quality 2019: 1062860619843350, 2019